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Introduction: Lesions of the ampulla of Vater are rare histological entities with an incidence of between 0.1 and
0.2% of gastrointestinal tumors. Until recently the main response to this kind of lesion was duodenopancreatectomy,
regardless of the cellular atypia and local edema. In this study, we propose the application of transduodenal local
excision of the ampulla of Vater especially in recognized cases of nonmalignant adenomas.
Case presentation: In this case report we analyze the case of a 78-year-old Greek man who revealed symptoms such
as icterus, abdominal pain without constipation and bloody stools. A physical examination showed painless swelling of
the gallbladder (Courvoisier sign). No previous abdominal operations or hernias were identified. Blood tests, computed
tomography scan analysis, gastroscopy and endoscopic retrograde cholangiopancreatography along with biopsies and
cytological tests diagnosed nonmalignant adenoma of the ampulla of Vater with high-grade dysplasia. The treatment
we followed was transduodenal local excision of his ampulla of Vater.
Conclusions: Transduodenal local excision of the ampulla of Vater has limited side effects and postoperative
complications, suggesting this particular technique to be the proper treatment for nonmalignant cases of adenomas.
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Adenoma of the ampulla of Vater is a difficult-to-diagnose
cause of obstruction of the biliary duct. It is among the
rarest of gastrointestinal neoplasms. It is usually identified
after gastroscopy followed by biopsies but often gets
misdiagnosed. It carries a significant rate of morbidity
and mortality.
Case presentation
In this study we present a case of a 78-year-old Greek
man who was diagnosed with adenoma of the ampulla
of Vater. He presented in the emergency room with
symptoms of abdominal pain without constipation and
bloody stools. A physical examination showed icterus
and Courvoisier sign.
The laboratory findings were: total bilirubin, 2.63mg/dL
(normal 0.3 to 1.5); direct bilirubin, 1.33mg/dL (normal
0.01 to 0.35); indirect bilirubin, 1.50mg/dL (normal 0.01
to 0.35); serum albumin, 3.14g/dL (normal 3.5 to 5.0);
alanine aminotransferase, 24U/L (normal 0 to 50); aspar-
tate aminotransferase, 34U/L (normal 0 to 40); c-glutamyl* Correspondence: argioannid@med.uoa.gr
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unless otherwise stated.transpeptidase, 27U/L (normal 0 to 40); alkaline phosphat-
ase, 136IU/L (normal 30 to 140); C-reactive protein
221mg/dL (normal 0 to 10); white blood cell 8300/μL
(normal 4000 to 10000); creatinine kinase 191U/L (24 to
195IU/L); carbohydrate antigen 19-9, 50.2U/mL (normal 0
to 37); cancer antigen 15-3, 45.2U/mL (normal 0 to 30).
Ultrasonography of his abdomen revealed cholelithiasis
and dilated intrahepatic and outer hepatic bile vessels. A
computed tomography (CT) scan analysis showed a mass
in his ampulla of Vater and pancreas, and revealed mul-
tiple calcified elements compatible with chronic pancrea-
titis (Figure 1). Lithiasis of his bile duct was also present.
Magnetic resonance imaging (MRI) could not be done be-
cause of his pacemaker.
Five days later endoscopic retrograde cholangiopan-
creatography (ERCP) was conducted. Entrance through
the ampulla of Vater was impossible but a biopsy was
taken for cytological examination. The histological analysis
showed nonmalignant disease.
Two days later common biopsies were taken during a
gastroscopy (Figure 2) process and the results revealed non-
malignant papillary adenoma with high-grade dysplasia.
Considering the size, the position and absence of ma-
lignancy we decided to proceed to transduodenal localLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The abdominal computed tomography showed a mass at the ampulla of Vater (arrows).
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transduodenal local excision of the adenoma of the am-
pulla of Vater, sphincterotomy of Oddi, followed by Oddi
sphincteroplasty, exploration of his common bile duct
and gastrointestinal anastomosis. Finally a Kehr tube
was placed in his common bile duct through the incision
of the exploration. The gastrointestinal anastomosis was
conducted to reduce the inner pressure at his duodenum.Figure 2 Gastroduodenal endoscopy showed a swollen
duodenal adenoma of the ampulla of Vater with white
mucosal covering.The length of the procedure was 2 hours and 13 minutes
and the estimated blood loss was approximately 280mL.
Transfusion was not necessary as the his postoperative
hematocrit was 35%.
One week later a postoperative cholangiography (Figure 3)
revealed no obstructions of his biliary tree and the results
of his biochemical blood tests were normal.
The final histological examination verified the biopsies
from the gastroscopy. More specifically, the excision speci-
men consisted of mucosal and submucosal regions of his
duodenum; it showed papillary adenoma with high-grade
dysplasia, nonspecific inflammation and local corrosions,
without evidence of malignancy (Figure 4).
He was discharged after a total of 16 days in our hospital.
Discussion
Lesions of the ampulla of Vater are rare histological en-
tities that in most cases have a high potential for malig-
nancy [1]. Until recently, the main response to this kind
of lesion was duodenopancreatectomy, regardless of the
histological type, malignancy and local edema. However,
improvements in diagnosis and therapy demonstrate the
proper operation to be endoscopic removal of the adenoma
when the tumor is detected. When endoscopic treatment is
not possible, ampullectomy is an important technique com-
pared with duodenopancreatectomy [1,2].
Adenoma of the ampulla of Vater was first described
in 1895 by Calzavara [3] and diagnosis was difficult until
1973 when it became possible to implement ERCP in
diagnosis of the biliary tree and pancreatic malformations.
Adenomas of the ampulla of Vater are rare neoplasms that
occur sporadically or in the context of genetic syndromes
Figure 3 The postoperative cholangiography reveals common
bile and pancreatic duct able to drain into the duodenum. The
arrow indicates the pancreatic duct.
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turn into malignant adenocarcinomas [4,5]. In terms of
histopathological classification of neoplasmatic lesions
of the ampulla of Vater, 40% are tubulovillous adenomas,
30% villous adenomas, 10% tubular adenomas and 20%
are nonepithelial lesions such as endocrine adenomas or
neurinomas. In addition, neoplasmatic lesions of the
ampulla of Vater were found to range from 0.063 to
0.21% [6,7].
Tumors of the ampulla of Vater are usually identified by
gastroscopy or ERCP. ERCP and endoscopic ultrasonographyFigure 4 The histological analysis of the sample of the ampulla
of Vater reveals adenoma with high-grade dysplasia and non-
specific inflammation with local corrosions.provide important information for the assessment of ad-
enomas. With these techniques we can properly assess the
intraductal extension of the tumor, demonstrating the best
possible staging of the tumor toward the CT, the MRI and
transabdominal ultrasound [8]. With the implementation
of the evaluation of ERCP, the evaluation of adenomas is
more accurate and intraduodenal surgical excision has be-
come the proper treatment.
Furthermore, once adenomas of the ampulla of Vater
have been identified they may be treated by surgical exci-
sion [8,9] and in patients with advanced size and cellular
atypia, the surgical resection of adenoma seems to be the
proper treatment option [10]. Although many patients re-
veal side effects after curative resection [11], most cases
exhibit limited complications. The main complications in-
clude pancreatitis, postoperative bleeding and biliary tree
inflammation [11].
Apart from intraduodenal resection of the ampulla of
Vater, a pancreaticoduodenectomy may be used for the
resection. This technique was first implemented in 1935
by Whipple et al. [12] and applied in a patient with car-
cinoma of the ampulla of Vater. In this study, the patient
died after 25 months because of liver metastasis. This
technique may be applied in cases of papillary adenocar-
cinoma and high-grade dysplasia. By contrast, Hoyuela
et al. [13] reported a research study with four patients
with adenomas of the ampulla of Vater who had a Whip-
ple operation and showed no evidence of disease recur-
rence. The major advantages of the Whipple operation are
the reduced risk of recurrence and the exclusion of spor-
adic adenomas presented in the ampulla of Vater. However,
the technique has significant drawbacks mainly increased
postoperative mortality and morbidity.
A research study conducting pancreaticoduodenec-
tomies for Vater adenomas showed a mortality rate of
up to 10% and morbidity rate from 25% to 65% [14]. In
recent years the morbidity and mortality rates have im-
proved but the longer hospitalizations have increased
the cost of hospital care and possibly change quality of
life [14,15].
In addition, patients with aggressive carcinoma of the
ampulla of Vater who were treated with local excision,
showed a high rate of recurrence after application of
transduodenal local excision and a low rate of recur-
rence after Whipple surgery [15,16], suggesting that the
application of transduodenal local excision is recom-
mended when benign tumors are detected by histological
analysis, as in our case.
Scientific data have already shown that the mortality
rate (<1%) and the hospitalization time are lower after
local ablation of adenomas of the ampulla of Vater. The
advantages are also the lack of conducting a laparotomy
and the necessity of general anesthesia [16-18], with the
proviso that the patient be subject to regular postoperative
Alexiou et al. Journal of Medical Case Reports 2014, 8:228 Page 4 of 4
http://www.jmedicalcasereports.com/content/8/1/228monitoring in order to determine the risk of recurrence.
Side effects such as pancreatitis and bleeding after trans-
duodenal local excision seem to be self-limited and usually
affected no more than 10% of patients. The temporary
drainage of the pancreatic duct by using stents such as in
our case may reduce postoperative acute pancreatitis.
Conclusions
Adenoma of the ampulla of Vater is a rare nonmalignant
tumor that cannot be diagnosed easily and carries signifi-
cant rates of mortality and morbidity. Our therapeutic
approach was selected in order to avoid postoperative
complications such as those that might occur with duode-
nopancreatectomy. Even if endoscopic ampullectomy has
been tried in some progressive institutions, further re-
search to compare those two methods needs to be carried
out in order to identify the proper therapy in cases of non-
malignant adenomas of the ampulla of Vater.
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